However, it has been shown that despite the generation of a large number of tumor-specific effector CD8+ T cells, tumor progression can still recur [17,18,19]; this is in part due to tumor-induced immunosuppression that can dampen the cytotoxicity of CD8+ T cells [20]. The gene discussed is CD8A; the disease is neoplasm.